# EDGAR Filing Document

**Accession Number:** 0000949858
**File Stem:** 0001193125-23-032536
**Filing Date:** 2023-2
**Character Count:** 22920
**Document Hash:** eaa636ca1f5eda39a593ddd66ea0e432
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-23-032536.hdr.sgml**: 20230210

**ACCESSION NUMBER**: 0001193125-23-032536

**CONFORMED SUBMISSION TYPE**: SC 13G/A

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20230210

**DATE AS OF CHANGE**: 20230210

**GROUP MEMBERS**: INNOVATION CREDIT FUND VIII-A, L.P.

**GROUP MEMBERS**: SVB INNOVATION CREDIT FUND VIII, L.P.

**GROUP MEMBERS**: SVB INNOVATION CREDIT PARTNERS VIII, LLC

**GROUP MEMBERS**: SVB INNOVATION CREDIT PARTNERS VIII-A, LLC

**SUBJECT COMPANY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** ACHIEVE LIFE SCIENCES, INC.
- **CENTRAL INDEX KEY:** 0000949858
- **STANDARD INDUSTRIAL CLASSIFICATION:** IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
- **IRS NUMBER:** 954343413
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A
- **SEC ACT:** 1934 Act
- **SEC FILE NUMBER:** 005-45969
- **FILM NUMBER:** 23611747

**BUSINESS ADDRESS:**
- **STREET 1:** 22722 29TH DR. SE
- **STREET 2:** SUITE 100
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98021
- **BUSINESS PHONE:** 425-686-1500

**MAIL ADDRESS:**
- **STREET 1:** 22722 29TH DR. SE
- **STREET 2:** SUITE 100
- **CITY:** SEATTLE
- **STATE:** WA
- **ZIP:** 98021

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** ONCOGENEX PHARMACEUTICALS, INC.
- **DATE OF NAME CHANGE:** 20080821

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SONUS PHARMACEUTICALS INC
- **DATE OF NAME CHANGE:** 19950825
**FILED BY**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** SVB FINANCIAL GROUP
- **CENTRAL INDEX KEY:** 0000719739
- **STANDARD INDUSTRIAL CLASSIFICATION:** STATE COMMERCIAL BANKS [6022]
- **IRS NUMBER:** 911962278
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** SC 13G/A

**BUSINESS ADDRESS:**
- **STREET 1:** 3003 TASMAN DR
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054
- **BUSINESS PHONE:** 4086547400

**MAIL ADDRESS:**
- **STREET 1:** 3003 TASMAN DRIVE
- **CITY:** SANTA CLARA
- **STATE:** CA
- **ZIP:** 95054

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** SILICON VALLEY BANCSHARES
- **DATE OF NAME CHANGE:** 19920703

------

------

**UNITED STATES** 

**SECURITIES AND EXCHANGE COMMISSION** 

**Washington, D.C. 20549** 

------

**SCHEDULE 13G/A** 

**Under the Securities Exchange Act of 1934** 

**(Amendment No. 2)\*** 

------

## Achieve Life Sciences, Inc.
**(Name of Issuer)** 

**Common Stock, par value $0.001 per share** 

**(Title of Class of Securities)** 

**004468500** 

**(CUSIP Number)** 

**December 31, 2022** 

**(Date of Event Which Requires Filing of this Statement)** 

------

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

☐ Rule 13d-1(b)

☒ Rule 13d-1(c)

☐ Rule 13d-1(d)

\* The remainder of this cover page shall be filled out for a reporting person's initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

The information required in the remainder of this cover page shall not be deemed to be "filed" for the purpose of Section 18 of the Securities Exchange Act of 1934 ("<u>Act</u>") or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

------

CUSIP No. **004468500**

1. &nbsp;&nbsp;&nbsp;&nbsp; Names of Reporting Persons. &nbsp;&nbsp;&nbsp;&nbsp; SVB Financial Group

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☐

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;858,382 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;858,382<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;858,382 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;858,382<sup>(1)</sup> |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 1,716,764<sup>(2)</sup>

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of
Class Represented by Amount in Row (9) &nbsp;&nbsp;&nbsp;&nbsp; 8.8%<sup>(3)</sup>

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; HC-CO-IA

(1) Consists of 429,191 shares of Common Stock issuable to SVB Innovation Credit Fund VIII, L.P., and 429,191
shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P., in each case as of December 31, 2022, upon the full exercise of contingent convertible debt. The exercise of such conversion is
subject to (i) the maximum aggregate number of Common Stock issuable to the Reporting Persons or other conversion right holders (if any) not exceeding 1,889,763 shares of Common Stock, as such number may be adjusted for stock splits, stock
dividends, reorganizations, recapitalizations and the like occurring after December 22, 2021 (the "Primary Conversion Limit") and (ii) the maximum aggregate number of shares of the Issuer owned or held by SVB Financial Group
beneficially and/or of record not exceeding 19.99% of the Issuer's then-total issued and outstanding shares of Common Stock (the "Secondary Conversion Limit").

(2) Consists of 858,382 shares of Common Stock issuable to SVB Financial Group, 429,191 shares of Common Stock
issuable to SVB Innovation Credit Fund VIII, L.P., and 429,191 shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P., in each case as of December 31, 2022, upon the full exercise of
contingent convertible debt, the exercise of which is subject to the Primary Conversion Limit and the Secondary Conversion Limit.

(3) Based on (i) 9,710,747 shares of Common Stock outstanding at November 10, 2022 as reported in the
Issuer's Form 10-Q filed with the Securities and Exchange Commission ("SEC") on November 14, 2022, (ii) 8,186,282 shares of Common Stock subsequently issued as reported in the Issuer's
Current Report on Form 8-K filed with the SEC on November 18, 2022, (iii) 858,382 shares of Common Stock issuable to SVB Financial Group, (iv) 429,191 shares of Common Stock issuable to SVB Innovation
Credit Fund VIII, L.P. and (v) 429,191 shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P., in each of cases (iii)-(v) as of December 31, 2022 and upon the full exercise of
contingent convertible debt.

------

1. &nbsp;&nbsp;&nbsp;&nbsp; Names of Reporting Persons. &nbsp;&nbsp;&nbsp;&nbsp; SVB Innovation Credit Partners VIII, LLC

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☐

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup> |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 429,191<sup>(1)</sup>

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of
Class Represented by Amount in Row (9) &nbsp;&nbsp;&nbsp;&nbsp; 2.3%<sup>(2)</sup>

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; OO

(1) Consists of 429,191 shares of Common Stock issuable to SVB Innovation Credit Fund VIII, L.P. as of
December 31, 2022 upon the full exercise of contingent convertible debt, the exercise of which is subject to the Primary Conversion Limit and the Secondary Conversion Limit.

(2) Based on (i) 9,710,747 shares of Common Stock outstanding at November 10, 2022 as reported in the
Issuer's Form 10-Q filed with the SEC on November 14, 2022, (ii) 8,186,282 shares of Common Stock subsequently issued as reported in the Issuer's Current Report on Form 8-K filed with the SEC on November 18, 2022 and (iii) 429,191 shares of Common Stock issuable to SVB Innovation Credit Fund VIII, L.P. as of December 31, 2022.

------

1. &nbsp;&nbsp;&nbsp;&nbsp; Names of Reporting Persons. &nbsp;&nbsp;&nbsp;&nbsp; SVB Innovation Credit Fund VIII, L.P.

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☐

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup>  |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup>  |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 429,191<sup>(1)</sup>

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of
Class Represented by Amount in Row (9) &nbsp;&nbsp;&nbsp;&nbsp; 2.3%<sup>(2)</sup>

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; PN

(1) Consists of 429,191shares of Common Stock issuable to SVB Innovation Credit Fund VIII, L.P. as of
December 31, 2022 upon the full exercise of contingent convertible debt, the exercise of which is subject to the Primary Conversion Limit and the Secondary Conversion Limit.

(2) Based on (i) 9,710,747 shares of Common Stock outstanding at November 10, 2022 as reported in the
Issuer's Form 10-Q filed with the SEC on November 14, 2022, (ii) 8,186,282 shares of Common Stock subsequently issued as reported in the Issuer's Current Report on Form 8-K filed with the SEC on November 18, 2022 and (iii) 429,191 shares of Common Stock issuable to SVB Innovation Credit Fund VIII, L.P. as of December 31, 2022.

------

1. &nbsp;&nbsp;&nbsp;&nbsp; Names of Reporting Persons. &nbsp;&nbsp;&nbsp;&nbsp; SVB Innovation Credit Partners VIII-A, LLC

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☐

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup>  |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup> |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 429,191<sup>(1)</sup>

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of
Class Represented by Amount in Row (9) &nbsp;&nbsp;&nbsp;&nbsp; 2.3%<sup>(2)</sup>

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; OO

(1) Consists of 429,191 shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P. as of December 31, 2022 upon the full exercise of contingent convertible debt, the exercise of which is subject to the Primary Conversion Limit and the Secondary Conversion Limit.

(2) Based on (i) 9,710,747 shares of Common Stock outstanding at November 10, 2022 as reported in the
Issuer's Form 10-Q filed with the SEC on November 14, 2022, (ii) 8,186,282 shares of Common Stock subsequently issued as reported in the Issuer's Current Report on Form 8-K filed with the SEC on November 18, 2022 and (iii) 429,191 shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P. as of December 31, 2022.

------

1. &nbsp;&nbsp;&nbsp;&nbsp; Names of Reporting Persons. &nbsp;&nbsp;&nbsp;&nbsp; Innovation Credit Fund VIII-A, L.P.

2. &nbsp;&nbsp;&nbsp;&nbsp; Check the Appropriate Box
if a Member of a Group (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; (a) ☐ (b) ☐

3. &nbsp;&nbsp;&nbsp;&nbsp; SEC Use Only

4. &nbsp;&nbsp;&nbsp;&nbsp; Citizenship or Place of
Organization &nbsp;&nbsp;&nbsp;&nbsp; Delaware

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 5. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 6. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Voting Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup> |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 7. | &nbsp;&nbsp;&nbsp;&nbsp;Sole Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;0 |
| &nbsp;&nbsp;&nbsp; Number of<br> Shares<br> Beneficially <br> Owned by<br> Each<br> Reporting<br> Person<br> With: | 8. | &nbsp;&nbsp;&nbsp;&nbsp;Shared Dispositive Power:<br>&nbsp;&nbsp;&nbsp;&nbsp;429,191<sup>(1)</sup> |

---

9. &nbsp;&nbsp;&nbsp;&nbsp; Aggregate Amount Beneficially Owned by Each Reporting Person &nbsp;&nbsp;&nbsp;&nbsp; 429,191<sup>(1)</sup>

10. &nbsp;&nbsp;&nbsp;&nbsp; Check if the Aggregate
Amount in Row (9) Excludes Certain Shares (See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; ☐

11. &nbsp;&nbsp;&nbsp;&nbsp; Percent of
Class Represented by Amount in Row (9) &nbsp;&nbsp;&nbsp;&nbsp; 2.3%<sup>(2)</sup>

12. &nbsp;&nbsp;&nbsp;&nbsp; Type of Reporting Person
(See Instructions) &nbsp;&nbsp;&nbsp;&nbsp; PN

(1) Consists of 429,191 shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P. as of December 31, 2022 upon the full exercise of contingent convertible debt, the exercise of which is subject to the Primary Conversion Limit and the Secondary Conversion Limit.

(2) Based on (i) 9,710,747 shares of Common Stock outstanding at November 10, 2022 as reported in the
Issuer's Form 10-Q filed with the SEC on November 14, 2022, (ii) 8,186,282 shares of Common Stock subsequently issued as reported in the Issuer's Current Report on Form 8-K filed with the SEC on November 18, 2022 and (iii) 429,191 shares of Common Stock issuable to Innovation Credit Fund VIII-A, L.P. as of December 31, 2022.

------

**Item 1.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Name of Issuer:** 

Achieve Life Sciences, Inc.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Address of Issuer's Principal Executive Offices** 

1040 West Georgia Street, Suite 1030

Vancouver, British Columbia, Canada V6E 4H1

**Item 2.**

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Name of Person Filing** 

SVB Financial Group

SVB Innovation Credit Partners VIII, LLC

SVB Innovation Credit Fund VIII, L.P.

SVB Innovation Credit Partners VIII-A, LLC

Innovation Credit Fund VIII-A, L.P.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Address of Principal Business Office or, if none, Residence** 

**SVB Financial Group** 

3003 Tasman Drive

Santa Clara, California

95054-1191

**SVB Innovation Credit Partners VIII, LLC** 

2770 Sand Hill Road

Menlo Park, CA 94025

**SVB Innovation Credit Fund VIII, L.P.** 

2770 Sand Hill Road

Menlo Park, CA 94025

**SVB Innovation Credit Partners VIII-A, LLC** 

2770 Sand Hill Road

Menlo Park, CA 94025

**Innovation Credit Fund VIII-A, L.P.** 

2770 Sand Hill Road

Menlo Park, CA 94025

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) **Citizenship** 

Each of the Reporting Persons is a citizen of Delaware.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d) **Title of Class of Securities** 

Common Stock

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(e) **CUSIP Number** 

004468500

------

**Item 3.** **If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:** <br>

Not Applicable.

**Item 4.** **Ownership.** <br>

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a) **Amount beneficially owned:** 

See the responses to Item 9 on the attached cover pages.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b) **Percent of class:** 

See the responses to Item 11 on the attached cover pages.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c) Number of shares as to which the person has:

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(i) **Sole power to vote or to direct the vote** 

See the responses to Item 5 on the attached cover pages.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(ii) **Shared power to vote or to direct the vote** 

See the responses to Item 6 on the attached cover pages.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iii) **Sole power to dispose or to direct the disposition of** 

See the responses to Item 7 on the attached cover pages.

&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(iv) **Shared power to dispose or to direct the disposition of** 

See the responses to Item 8 on the attached cover pages.

**Item 5.** **Ownership of Five Percent or Less of a Class.** <br>

Not Applicable.

**Item 6.** **Ownership of More than Five Percent on Behalf of Another Person.** <br>

Not Applicable.

**Item 7.** **Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company.** <br>

See Exhibit 99.2.

**Item 8.** **Identification and Classification of Members of the Group.** <br>

Not Applicable.

**Item 9.** **Notice of Dissolution of Group.** <br>

Not Applicable.

**Item 10.** **Certification.** <br>

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under §240.14a-11.

------

**SIGNATURE** 

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: February 10, 2023

---

| | |
|:---|:---|
| **SVB Financial Group** | **SVB Financial Group** |
| By | /s/ Karen Hon |
| Name: | Karen Hon |
| Title: | Chief Accounting Officer |
| **SVB Innovation Credit Fund VIII, L.P.** | **SVB Innovation Credit Fund VIII, L.P.** |
| By: | SVB Innovation Credit Partners VIII, LLC, its general partner |
| By | /s/ Andrew Olson |
| Name: | Andrew Olson |
| Title: | Chief Financial Officer |
| **SVB Innovation Credit Partners VIII, LLC** | **SVB Innovation Credit Partners VIII, LLC** |
| By | /s/ Andrew Olson |
| Name: | Andrew Olson |
| Title: | Chief Financial Officer |

---

[*Signatures continue on next page*]

------

---

| | |
|:---|:---|
| **Innovation Credit Fund VIII-A, L.P.** | **Innovation Credit Fund VIII-A, L.P.** |
| By: SVB Innovation Credit Partners VIII-A, LLC, its general partner | By: SVB Innovation Credit Partners VIII-A, LLC, its general partner |
| By | /s/ Andrew Olson |
| Name: | Andrew Olson |
| Title: | Chief Financial Officer |
| **SVB Innovation Credit Partners VIII-A, LLC** | **SVB Innovation Credit Partners VIII-A, LLC** |
| By | /s/ Andrew Olson |
| Name: | Andrew Olson |
| Title: | Chief Financial Officer |

---

------

**INDEX TO EXHIBITS** 

---

| | |
|:---|:---|
| Exhibit 99.1 | Joint Filing Agreement (incorporated by reference to Exhibit 99.1 to the Schedule 13G filed by the Reporting Persons with the SEC on December 29, 2021) |
| Exhibit 99.2 | Item 7 Information (incorporated by reference to Exhibit 99.2 to the Schedule 13G filed by the Reporting Persons with the SEC on December 29, 2021) |

---